ABBV Abbvie Inc

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

$114.70  -0.03 (-0.03%)
As of 06/22/2021 16:04:24 EST     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  12/10/2012
Outstanding shares:  1,766,222,336
Average volume:  6,482,517
Market cap:   $199,795,070,648
Current dividend yield:  4.31%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00287Y109
ISIN:        US00287Y1091
Sedol:      B92SR70

---

Valuation   (See tab for details)

---

PE ratio:   39.28
PB ratio:   14.78
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%